People should be paid for donating an organ

October 05, 2006

A legalised and regulated system for paying people to donate organs should be created to help answer the large demand for transplants and prevent exploitation of poor people, says an article in this week's BMJ.

The author - an organ transplant surgeon - has written an opinion piece arguing for payments to be made for live organ donation, saying it does not go against current ethical practice in healthcare and would help with the "desperate" need for organs.

Many people who agree to participate in medical research do so for financial reward, points out the author Amy Friedman, associate professor of surgery at Yale University School of Medicine in the USA.

"If it is reasonable, legal, and ethically justified to motivate someone using monetary reward to participate in human research, then by extension the same person should be allowed a monetary inducement or reward for donating an organ," writes Professor Friedman.

The buying and selling of regenerative products such as human hair, blood and semen occurs and human eggs are now sought openly with a price offered for them - payment is legal in the USA.

Professor Friedman says proper supervision of a transplant process would minimise potential medical and surgical harm and might be accomplished through a centralised, multi-disciplinary panel with responsibility for determining standardised criteria for donors and recipients as well as a uniform fee.

Kidneys are covertly transplanted in third world countries at the moment from poorer people to wealthier recipients, she says, with little evidence of the outcomes.

"Bringing these activities out of the closet, by introducing governmental supervision and funding will provide equity for the poor, who will get equal access to such transplants."
Payment for living organ donation should be legalized BMJ Volume 333, pp 746-8


Related Transplants Articles from Brightsurf:

Enzyme biofactories to enhance cord blood transplants
Stem cell trafficking to the bone marrow is improved by enzyme manufactured in silkworms and yeast.

Yale succeeds with a more inclusive approach to heart transplants
Doctors at Yale New Haven Hospital used a more aggressive selection process to more than quadruple the number of heart transplants performed there while maintaining positive patient outcomes, according to a new study.

Heart transplants declined sharply during pandemic
Heart transplants, donor hearts, and transplant waitlists all fell sharply at the start of the COVID-19 pandemic in the United States, Columbia University researchers have found.

Heart transplants from donors positive for hepatitis C
Researchers at Vanderbilt University Medical Center in Nashville, Tenn., report in this case series on 80 patients who had heart transplants using hearts from donors positive for hepatitis C.

Robotic transplants safe for kidney disease patients with obesity
Researchers report that among patients with obesity, robotic kidney transplants produce survival outcomes comparable to those seen among nonobese patients.

Viagra shows promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem cells for bone marrow transplants using a combination of Viagra and a second drug called Plerixafor.

Is ownership of dialysis facilities associated with access to kidney transplants?
An analysis that included data for nearly 1.5 million patients with end-stage kidney disease looked at whether ownership of dialysis facilities was associated with patients' access to kidney transplants.

Poo transplants to help save koalas
Poo transplants are helping expand koala microbiomes, allowing the marsupials to eat a wider range of eucalypts and possibly survive habitat loss.

Antibiotics before liver transplants lead to better results
A UCLA-led research team has found that giving mice antibiotics for 10 days prior to a liver transplant leads to better liver function after the surgery.

Genomic collision may explain why many kidney transplants fail
Up to 1 in 7 kidney donors and recipients may have a type of genetic incompatibility that leads to organ rejection, researchers at Columbia University have found.

Read More: Transplants News and Transplants Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to